Teachers Advisors’s Moderna MRNA Stock Holding History

Teachers Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$580K	Buy	+28,511	New	+$529K	﹤0.01%	2491

Other funds holding MRNA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Teachers Advisors's MRNA Position: Q1 2019 in Review

Teachers Advisors opened a new position in Moderna (MRNA) in Q1 2019: 28,511 shares worth $580K. The stake represents ﹤0.01% of the portfolio and ranks #2491 among its holdings.

106 funds tracked by Wall St. Rank hold MRNA as of Q1 2019.

Teachers Advisors held 28,511 shares of Moderna worth $580K as of Q1 2019.
Moderna was a new Teachers Advisors position in Q1 2019.
Moderna made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2491 holding.
106 funds tracked by Wall St. Rank held Moderna as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.